The Defense Health Agency awarded a single-award blanket purchase agreement to Genomic Health, Inc., a division of Exact Sciences Corporation, for diagnostic services for oncology prostate testing. The potential value of the agreement is $5,000,000 to be utilized over four years through individual task order calls. The agreement aims to support the Agency's efforts to advance cancer screening and personalized treatment selection through Genomic Health's Oncotype Portfolio of genomic tests for...
The Department of Veterans Affairs (VA), Veterans Integrated Service Network (VISN) 22 awarded a single-award Blanket Purchase Agreement (BPA) to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, for Oncotype genetic testing services. The BPA has a ceiling value of $970,352 and a period of performance from February 2023 through February 2028. Under this IDV, the VA can order cancer screening, treatment selection, and disease monitoring testing services on an as-needed basis at...
The federal contract IDV award is for Decipher Prostate Genomic Classifier testing services provided by Veracyte Labs SD Corporation, a division of Veracyte, Inc., to the Department of Veterans Affairs (VA). The single-award Indefinite Delivery Contract has a ceiling value of $194,435.40 and a period of performance through September 30, 2026. Under this IDV, Veracyte will deliver task orders for Decipher Prostate Cancer testing to support the VA's efforts to provide personalized cancer care...
Quest Diagnostics Incorporated has been awarded an indefinite delivery contract by the Department of the Air Force Air Combat Command to provide laboratory testing and research services. The contract has a potential value of $500,000 and was awarded on September 25, 2020 as a single award, non-set aside agreement.
Under this contract vehicle, Quest Diagnostics has received multiple delivery orders to date for work conducted through its division Quest Diagnostics-Nevada located at Nellis Air...
This federal contract IDV is a Blanket Purchase Agreement (BPA) awarded by the Veterans Integrated Service Network 17 (VISN 17) of the Department of Veterans Affairs (VA) to Mdxhealth, Inc., a for-profit healthcare company that provides molecular diagnostic services. The BPA, issued under Mdxhealth's existing General Services Administration (GSA) Federal Supply Schedule contract for Medical Laboratory Testing and Analysis Services, has a ceiling value of $320,000 and a period of performance...
The federal contract IDV award, valued at up to $890,640.00, was issued by the Department of Veterans Affairs' (VA) Veterans Integrated Service Network 16 (VISN 16) to Veracyte, Inc., a for-profit provider of genomic testing services. The single-award IDV, awarded on October 1, 2024 with a potential completion date of September 30, 2029, will enable VISN 16 to efficiently access Veracyte's commercial laboratory capabilities for specialized pathology testing to support VA hospitals and clinics...
The federal contract IDV is an Indefinite Delivery Contract awarded by the Department of the Army Medical Command to Gen-Probe Incorporated, a medical diagnostics company, with a ceiling value of $2,073,793.50. Through this contract and associated delivery orders, Gen-Probe provides a variety of medical testing products and services to the Defense Health Agency, Department of Veterans Affairs, and Department of the Navy, including APTIMA combo assay test kits for chlamydia and gonorrhea,...
This federal contract IDV is a Blanket Purchase Agreement (BPA) awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 17 to Mdxhealth, Inc., a for-profit healthcare company specializing in cancer diagnostics. The BPA, with a total ceiling value of $4,800,000, is for the provision of Oncotype DX prostate cancer testing services under the VA's Medical Laboratory Testing and Analysis Services Federal Supply Schedule contract. The period of performance...
The U.S. Department of Veterans Affairs (VA) awarded a $130.7 million Indefinite Delivery Contract (IDC) to Foundation Medicine, Inc., a leading provider of genomic profiling and molecular analysis services, for specialized tumor molecular profiling services. This single-award IDC, with a completion date of September 12, 2029, aims to provide the VA's National Precision Oncology Program with comprehensive genomic profiling for both solid and hematological malignancies. The contracted services...
The Indefinite Delivery Contract awarded by the Department of the Air Force Air Combat Command is a single award contract to Biofire Defense LLC for Biofire test kits and reagents. With a potential value of $1.7 million and a period of performance through July 2028, the contract enables the 99th Medical Group to issue delivery orders for diagnostic products over the next five years in support of their biological detection operations.
No set-aside was used for this SBIR Phase III contract...